| Literature DB >> 15789561 |
Alexander Dömling1, Wolfgang Richter.
Abstract
Tubulin-binding agents play a pivotal role in current cancer therapy and there are many efforts in pre-clinical and clinical development of known and novel cytotoxic agents ongoing. In this article a known class, epothilones, as well as a novel class, tubulysins, are presented.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15789561 DOI: 10.1007/s11030-005-1542-0
Source DB: PubMed Journal: Mol Divers ISSN: 1381-1991 Impact factor: 2.943